AGFB Agfa-Gevaert NV

Publication of a transparency notification – Regulated information

Publication of a transparency notification – Regulated information

                                       

Publication of a transparency notification – Regulated information

(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings)

Mortsel, Belgium – June 19, 2023 – 7.45 a.m. CET



According to Agfa-Gevaert NV’s bylaws, the threshold as from which a shareholding needs to be disclosed, has been set at 3%, 5% and a multiple of 5%.

In conformity with the Law of May 2, 2007 regarding the disclosure of significant shareholdings in listed companies, Agfa-Gevaert (Euronext: AGFB) discloses the following declaration:

Sheffield Asset Management, L.L.C. declared on June 15, 2023, that it has crossed the 3% threshold downwards on June 14, 2023 (denominator is 154,820,528).

Full chain of controlled undertakings

Sheffield Asset Management, L.L.C. acting on behalf of Sheffield Partners, L.P. ("the Fund"). Sheffield Asset Management, L.L.C. is the general partner of the Fund and exercises the voting rights associated with the shares held in the Fund. Sheffield Asset Management, L.L.C. has two members, Brian J. Feltzin, Trustee of the Brian J. Feltzin Revocable Trust, u/a/d May 11, 2004 (the Managing Member) and Allison Feltzin (the Non-Managing Member). Brian J. Feltzin and Allison Feltzin are not the beneficial owners of the shares, which are owned by the Fund. Sheffield Asset Management Llc is not a controlled entity.

Additional information

Sheffield Asset Management, L.L.C. is the investment management company that exercises the voting rights of Sheffield Partners, L.P. at its discretion in the absence of specific instructions.

Notifications of important shareholdings to be made according to the Law of

May 2, 2007 or Agfa-Gevaert NV’s bylaws, should be sent to .

About Agfa-Gevaert

The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds three divisions: Radiology Solutions, HealthCare IT and Digital Print & Chemicals. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2022, the Group (including the Offset Solutions division) realized a turnover of 1,857 million Euro.

Contact:

Viviane Dictus

Director Corporate Communications

tel. 4

e-mail:

Attachment



EN
19/06/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agfa-Gevaert NV

 PRESS RELEASE

Agfa announces additional measures to adjust the cost base of its trad...

Agfa announces additional measures to adjust the cost base of its traditional film activities to the reality in the market December 4, 2025 – 7:45 a.m. CET Regulated information Agfa announces additional measures to adjust the cost base of its traditional film activities to the reality in the market Mortsel, Belgium – December 4, 2025 – 7:45 a.m. CET Agfa today announced that it plans to implement additional measures to adjust the cost base of its traditional film activities to the accelerated global market decline. These measures are an extension to the plan that was announced in Novem...

 PRESS RELEASE

Agfa kondigt bijkomende maatregelen aan om de kostenbasis van zijn tra...

Agfa kondigt bijkomende maatregelen aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt 4 december 2025 – 7:45 uur CET Gereglementeerde informatie Agfa kondigt bijkomende maatregelen aan om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de realiteit in de markt Mortsel, België – 4 december 2025 – 7u45 Agfa kondigde vandaag aan dat het van plan is bijkomende maatregelen te nemen om de kostenbasis van zijn traditionele filmactiviteiten aan te passen aan de versnelde achteruitgang van de wereldwijde markten. Deze...

Guy Sips ... (+4)
  • Guy Sips
  • Jacob Mekhael
  • Livio Luyten
  • Wim Hoste
Guy Sips
  • Guy Sips

Agfa “Shrinking Business” & “Not-So-Growth Engines”

After three quarters, Agfa's 9M25 “Mature Business” (Radiology and Film DPC) sales dropped -6.4% y/y, driven by the accelerating medical film decline. While its “Growth Engines” (HealthCare IT, Digital Printing Solutions, Green Hydrogen Solutions) are intended to offset this, they also fell -0.9% y/y in the first nine months. We remain cautious (Hold; €1.0 Target Price) until strategic measures deliver and growth engines regain momentum.

Guy Sips
  • Guy Sips

Agfa Decline in medical film was even stronger than expected

Agfa's 3Q25 continued decline in medical film was even stronger than expected (€ 257m 3Q25 sales vs € 275m KBCS & CSS). Although the growth in cloud/SaaS in HealthCare IT all the divisions were below our and CSS forecasts as well on top-line as on REBIT-margins. The increase in Digital Printing & Chemicals was not sufficiently offsetting the impact from the decline in medical film and from cloud transition in HealthCare IT. Despite good cost control, REBIT decreased to -4m, mainly due to the d...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch